Centers for Disease Control and Prevention (CDC) has purchased HP BioPrinters for the Antibiotic Resistance (AR) Lab Network to accelerate testing of new antibiotics at the local level.
“Bacteria continuously develop new ways to resist antibiotics—once a drug is used, the countdown starts for how long it will be effective. To save lives and protect people, CDC and HP are making the D300e technology accessible to hospital labs nationwide. This project will help ensure our newest drugs last longer and will put gold-standard lab results in healthcare providers’ hands faster.”
- Dr. Jean Patel, microbiologist and science lead for CDC’s Antibiotic Resistance (AR) Laboratory Network